Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis

BACKGROUND: Hemocoagulase batroxobin is used to prevent hemostasis or bleeding in surgical and trauma patients; however, the role of batroxobin in patients with hemoptysis is not well understood. We evaluated the risk factors and prognosis of acquired hypofibrinogenemia in hemoptysis patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae-Kyeong, Yoon, Chang-Seok, Na, Young-Ok, Park, Hwa Kyung, Oh, Hyung-Joo, Kho, Bo-Gun, Park, Ha-Young, Kim, Tae-Ok, Shin, Hong-Joon, Kwon, Yong-Soo, Kim, Yu-Il, Lim, Sung-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922611/
https://www.ncbi.nlm.nih.gov/pubmed/36794140
http://dx.doi.org/10.21037/jtd-22-717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922611/
https://www.ncbi.nlm.nih.gov/pubmed/36794140
http://dx.doi.org/10.21037/jtd-22-717

Ejemplares similares